Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2867_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
15 Мб
Скачать
☆
44 Human Immunodeciency Virus (HIV) Misdiagnosed asPharyngitis
cross-sectional study in an urban area in Brazil [8]. The most important risk factors reported were male gender (adjusted odds ratio 3.02, 95% CI 2.0–4.6), provider­initiated testing (3.0, 95% CI 2.1–4.4), and age of 45+ years (1.67, 95 %CI 1.1–2.5). These factors may vary per country: in the United States, Chin and coworkers found men to be three times more likely than women to be diagnosed with HIV-1 on their rst physician consultation [14].
327
Psychological Aspects ofHIV andinPatients Contemplating thePossibility that They Might Have HIV
– Discuss the psychological effect of misdiagnosis of HIV. – WBC count and others would have been considered directly and the effect on the
probability of misdiagnosis of HIV.

Plan of Action, the Points Clinician Should Consider, Pitfalls to Avoid, and Pearls of Knowledge to Consider

The basics should not be overlooked:
1. When a patient presents, a careful and detailed medical history should be taken,
and pathognomonic and important details should be considered. Risky sexual behavior points in the direction of HIV or other sexually transmitted disease, until proven otherwise.
2. Also in the primary healthcare practice, a thorough physical examination is a
must, even or especially when the medical history seems trivial.
3. Physicians should be trained and upgraded in order to have sufcient up-to-date
STD knowledge [13, 15].
4. Evaluate carefully the characteristics of each diagnostic tool: in the case of a labo-
ratory, evaluate carefully which test to be used in which stage of a disease. In the case of HIV, the gold standard for the early phase is a PCR test, which is sensitive from the early phases and also has a high percentage of true-negative results.
5. In case a laboratory test is not in concert with the medical history and the physi-
cal examination, do not drop the diagnosis, but take into account possible false­negative results of the laboratory tests.

Conclusion

Third-generation HIV antigen tests should be avoided in the acute phase of HIV infections, due to the high rate of false-negative test results. A fourth-generation test or, preferably, PCR testing should be used.
328
S. Keli

References

1. Medina-De la Garza C, De los Angeles Castro-Corona M, Salinas-Farmona C.Near misdi­agnosis of acute HIV-infection with ELISA-Western blot scheme: time for mindset change. IDCases. 2021; https://doi.org/10.1016/j.idcr.2021.e01168.
2. Crowell TA, Colby DJ, Pinyakorn S, etal. Acute retroviral syndrome is associated with high viral burden, CD4 depletion, and immune activation in systemic and tissue components. Clin Infect Dis. 2018;66:1540–9.
3. Stuyf T, Deeks J, Dinnes J, etal. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev 2021, Issue 2. Art. No.: CD013665.
4. Rahman S, Villagomez Montero MT, Rowe K, etal. Epidemiology, pathogenesis, clinical pre­sentations, diagnosis and treatment of COVID-19: a review of current evidence. Exp Rev Clin Pharm. 2021:1–7. https://doi.org/10.1080/17512433.2021.1902303.
5. Lai C, Wang C, Hsueh P. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53:505e512.
6. Le T, Wright E, Smith D, etal. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretrovi­ral therapy. N Engl J Med. 2013;368:218–30.
7. Walker B, Hirsch M.Antiretroviral therapy in HIV-1in early HIV-1 infection [editorial]. N Engl J Med. 2013;368:279–81.
8. MacCarthy S, Hoffmann M, Nunn A, etal. Barriers to HIV testing, linkage to care, and treat­ment adherence: a cross-sectional study from a large urban center of Brazil. Rev Panam Salud Publica. 2016;40:418–26.
9. Cohen MS, Chen YQ, McCauley M, etal. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375:830–9.
10. World Health Organization. Consolidated guidelines on HIV prevention, testing, treat­ment, service delivery and monitoring: recommendations for a public health approach; 978–92–4-003159-3. July 2021.
11. Centers for Disease Control and Prevention and Association of Public Health Laboratories. Laboratory testing for the diagnosis of HIV infection: updated recommendations. 2014;
https://doi.org/10.15620/cdc.23447. Published June 27.
12. Centers for disease control and prevention and Association of Public Health Laboratories. Laboratory testing for the diagnosis of HIV infection: updated recommendations. Published January 2018.
13. Tan K, Black BP.A systematic review of health care provider-perceived barriers and facilita­tors to routine HIV testing in primary care settings in the southeastern United States. Assoc Nurses AIDS Care. 2018;29(3):357–70. https://doi.org/10.1016/j.jana.2017.12.006. Epub 2017 Dec 27
14. Chin T, Hicks C, Samsa G, MckKellar M.Diagnosing HIV infection in primary care set­tings: missed opportunities. AIDS Patient Care STDs. 2013;27:392–7. https://doi.org/10.1089/
apc.2013.0099. Epub 2013 Jun 25
15. Gebre Y, Forbes N, Peters A.Review of HIV treatment progress, gaps, and challenges in the Caribbean, 2005–2015. Rev Panam Salud Publica. 2016;40:468–73.
Chapter 45
Early Lyme Disease Misdiagnosed asInuenza
SirvingKeli
Learning Objectives
By the end of this presentation, the clinician will be able to:
1. Create an appropriate differential diagnosis in patients presenting with symp­tomatology that seems u-like, but may carry signs of early Lyme disease, in the consciousness that seemingly trivial symptoms and signs can only be put in the right context where the patient is observed and carefully examined combined with an extensive medical history taking including possible travel, occupational, and recreational and/or weather- and disaster-related exposures.
2. Evaluate the different components of the medical history, especially occupa­tional, recreational, and weather- and disaster-related information, and in-person physical examination which indicate the most appropriate order within the dif­ferential diagnosis and hence the most correct course of further diagnostic pro­cedures needed to reach a denitive diagnosis.
3. Analyze the clinical presentation of the symptoms and signs, including those pointing clearly to Lyme disease, in order to choose the most appropriate diag­nostic tools, including radiographic and laboratory testing.
4. Apply the appropriate panel of diagnostic instruments when Lyme disease is part of the differential diagnosis, given the potential serious clinical evolution and long-term sequelae of Lyme disease.
S. Keli (*) St. Martinus University Faculty of Medicine, Willemstad, Curacao e-mail: sirving.keli@martinus.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 H. Tohid et al. (eds.), The Misdiagnosis Casebook in Clinical Medicine,
https://doi.org/10.1007/978-3-031-28296-6_45
329
330
S. Keli
5. Discuss the potentially serious consequences of a misdiagnosis or delay in reach­ing a correct diagnosis when the patient is handled only by phone, and not seen, observed, and examined in person.
6. Recognize the different faces and disguises Lyme disease may present itself with, especially in the early stage.

Introduction

Lyme disease may be easily missed, but nonetheless consequences remain serious. Caused by infected ticks carrying Borrelia burgdorferi, the typical appearance with the bite marks is the most immediate visible sign, if present. The presence of ery­thema migrans is an important sign, but might not always be visible. In contrast to North America where Borrelia burgdorferi is responsible for the majority of the infections, Borrelia afzelii and Borrelia garinii are causing the most infections in Europe [1]. However, especially in the Midwest of the United States of America, also Borrelia mayonii has been identied [2]. The infection of humans occurs by tick bites from ticks belonging to the Ixodes ricinus complex [1].
The treatment of Lyme disease consists of doxycycline and is in the majority of cases successful [1, 3]. However, in some cases, patients may show persistent clinical symptoms and signs despite treatment without evidence of treatment failure, relapse, or reinfection [3–6]. Klempner and coworkers determined that re-treatment of this group of patients was not only lacking benet, but even carried signicant risks [5]. Although at rst hand the disease seems innocent, the infection becomes dissemi­nated quickly with the patient. Acute neuroborreliosis may follow within weeks. It is estimated that this happens in one sixth of patients in the United States [6–8]. A seri­ous clinical picture may subsequently evolve, with neck stiffness and meningitis, encephalitis, neuropathy, and other neurologic manifestations [7, 8]. In approxi­mately 5% of patients, cardiac manifestations may be expressed by atrioventricular block, myocarditis, or fatal pancarditis [8]. Arthritis expresses itself through inter­mittent pain and joint swelling in large joints, with a predilection for knees [8], in approximately 60% of patients, starting months after the start of the disease, with 10% of all patients experiencing chronic persistent arthritis [8], is a late manifesta­tion of Lyme disease [8, 9]. The extensive damage is the result of inammatory reac- tions in the patient, which require only a small amount of bacteria in the tissues [9]. Also, Borrelia burgdorferi has a more extensive migration to different tissues than the other subtypes. This explains the difference between the mostly mild evolution of Lyme disease in Europe, where the agent most of the time is Borrelia afzelii, com- pared to North America, where Borrelia burgdorferi is the most prevalent agent [7–9].
In contrast to these serious symptoms and signs during the evolution of Lyme disease in a patient, before the multiplication and quick spread of the bacteria in the infected patient [9], the rst presentation may be a very mild, inuenza-like set of symptoms and signs, which may be misleading, as was the case in the clinical pre­sentation [10]. It takes 2–3weeks before the rst humoral antibodies are formed and become detectable as IgM through ELISA in laboratory testing [11–13]. If present,
45 Early Lyme Disease Misdiagnosed asInuenza
the erythema migrans, resulting from inammation of the skin by Borrelia, is a key nding, together with the exposure history of the patient. The case series discussed here [10] shows the important role both the exposure history, as obtained from the medical history, and the presence of the erythema migrans play, in preventing a misdiagnosis in early Lyme disease.
331

Clinical Case Presentation

Aucott and Seifter described in 2011 a case of a 58-year-old woman, otherwise healthy, who had a phone consultation with the physician based on “u-like” symp­toms, including headache, generalized achiness, and a subfebrile temperature of
101.2° F (38.44° C), without cough [10]. Based on the phone consultation, the most probable working diagnosis adopted was acute inuenza. Tamiu twice per day 75mg brought no improvement; that treatment was continued and after 2 days a sore throat resulted as the only symptom in the clinical spectrum. Also, the subfe­brile temperature remained unchanged. Besides, the remainder of the clinical pic­ture, regarding the generalized achiness and sore throat, also persisted without any improvement or worsening. Given this (lack of) development in the clinical picture, the Tamiu twice 75mg per day was maintained for the following days. However, after a welt on her stomach and generalized joint pain were reported on the 4th day, and also the patient remembered being bitten by something behind her knee with subsequent local irritation, she was invited for a physical consultation with her phy­sician. The bite was estimated to have taken place 3 weeks before the u-like symp­toms started. On the subsequent physical examination, two lesions consistent with erythema migrans were observed behind her knee, as well as a second and third lesion in the abdominal lateral region. No other abnormal observations were done during the physical examination. Laboratory analysis revealed elevated AST and ALT liver enzymes with a value of 413 and 704, respectively, with alkaline phos­phatase being 202. Subsequent serological analysis on the presence of Lyme anti­bodies with ELISA was performed. The results indicated a positive IgM and IgG [10]. Based on the results of the medical history during the live consultation, the results of the physical examination, and the laboratory results, the diagnosis of early Lyme disease was conrmed. Administering doxycycline made the patient recover from the rashes in 1 week, and remaining symptoms as well as the elevated liver enzymes quickly subsided during the next 2 weeks [10].

Differential Diagnosis

1. Lyme disease: In presence of the typical erythema skin lesion which is recogniz-
able by the typical bull’s-eye appearance with a center lesion and a centrifugal ring formation of inamed skin (rash), the primary diagnosis to be considered is Lyme disease, especially when there is a medical history of tick bite or soaring locations
332
of the skin. In early stages, even in absence of the erythema migrans, ticks might still be present at the site(s) of the bite(s). Although the other symptoms might resemble u (general weakness, fever, etc.), the erythema migrans is highly predic­tive for Lyme disease. In absence of the erythema, a history of tick bites and/or ticks still present at the site must lead to the consideration of Lyme disease, since it will typically take 7 to 14days for the erythema to develop, but this is the case in only 70–80% of the patients. Preventive treatment might be given in this case.
2. Inuenza: The initial presentation of inuenza, with several symptoms such as
general weakness, fever, runny nose, conjunctivitis, and myalgia, may resemble Lyme disease during the rst days; however, the medical history typically does not include insect bites, but absence of runny nose, conjunctivitis, and frequent cough and sore throat may plead against inuenza, especially during summer/ tick bite season. Also, initial treatment with doxycycline 100mg per day during 10days will have no effect on the clinical picture, in contrast to Lyme disease, which will disappear in most cases. Also the laboratory presentation of espe­cially white blood cells differs from Lyme disease.
3. HIV acute retroviral syndrome: The acute retroviral syndrome may also resem-
ble u in its early presentation; however a key nding in the medical history is the presence of recent sexual behaviors carrying the risk of HIV infection, com­bined with generalized lymphadenopathy. Key laboratory ndings indicating HIV infection are the lowered CD4+ cell count and the positive fourth- generation screening HIV tests conrmed by fourth-generation PCR testing.
S. Keli
What WasMisdiagnosed inThis Case andWhy?
Lyme disease was misdiagnosed as summer inuenza A, as a result from a diagnosis made by a phone consultation, without taking into account the patient’s exposure history and also without seeing the patient and without performing a physical exam­ination on the patient. No laboratory testing was performed either. The misdiagnosis could have been avoided if the patient was seen personally, and a complete medical history, physical examination and laboratory evaluation would have been done.

Discussion

A physician’s consultation through the phone is extremely sensitive to misdiagno­sis, especially in case of a rst presentation of a health condition by a patient. The consultation is then limited to a listen and ask conversation, and important details captured by vision and interaction with the patient are lost. The medical history is to be taken extensively, despite any busy physician’s ofce. It is the medical history that is able to reveal occupational, recreational, travel, and other exposure details that from a patient’s perspective may be trivial but for the physician’s differential
45 Early Lyme Disease Misdiagnosed asInuenza
333
diagnosis may be holding the key. As in many cases of misdiagnosis, with the initial presentation of the patient with u-like symptoms and signs, it is the medical history about possible exposures that will hint in the correct direction. Furthermore, only if the physician takes this into account and the concerning questions are asked to the patient will the key information come to light. In the current case, it was when the symptoms and signs persisted and extended that the direction was found. An impor­tant condition is that the physician should be well aware of the related exposures and exposure conditions in relation to the clinical picture presented. In the case report described above [10], it was not possible for the physician to have a physical examination of the patient during the telephone consultation; however, if physical inspection would have been done, either the rash or the previously present typical tick bites, with or without one or more ticks still present, would have been observed. Especially when patients do not consider physical locations to be relevant to their symptoms and signs or when patients cannot look at their body areas properly, the actual presence at the doctor’s ofce and the physical examination make the differ­ence. The presence of erythema migrans, recognizable by the annular rash spread­ing centrifugally, and which develops in the rst 7 to 14 days after infection [7–9], is a key nding and results from several alterations of the skin with development of several inammatory markers in the skin, which is where the rst immune response process against Borrelia burgdorferi takes place. Furthermore, Marques and coworkers have shown that during the skin inammation, a local immunosuppres­sion process evolves, which permits and mediates the quick spread of Borrelia to elsewhere in tissues and organs of an infected patient [14]. It is therefore fundamen­tal to diagnose Lyme disease in a patient as early as possible and start treatment immediately, since delays in treatment with subsequent hematogenous dissemina­tion may lead to a more serious clinical picture including neurological, cardiac, and long-term arthritis complications [3, 7, 8]. Steere documented the erythema migrans skin lesion to be the earliest manifestation of Lyme disease, present in 70–80% of patients within 7 to 14days after a tick bite [7]. Since both neurologic (10–15%) and cardiac symptoms (1–2%) may develop already from within weeks up to months after a tick bite [15], any delay in diagnosis must be avoided. The typical Lyme disease arthritis, which affects isolated large joints and has a pattern of migration in time, may affect up to 30% of patients and occurs mostly around 6months or longer after a tick bite.
The clinical and serological evolution of Lyme disease is summarized in the fol­lowing illustration.
334
S. Keli
Diagnosis ofLyme Disease
Diagnostic criteria of Lyme disease are based on the erythema migrans and/or the nding of Borrelia antibodies by laboratory testing of serum of suspected patients [12, 15]. In case Lyme disease is considered in the absence of the erythema migrans, the serologic tests will conrm the diagnosis. The procedure of laboratory testing is a two-step procedure, in which rst an EIA (enzyme immunoassay) is performed, which if positive may be followed by the second step which consists of IgM testing of the serum. IgG becomes positive typically later during the disease.

Plan of Action, the Points Clinician Should Consider, Pitfalls to Avoid, and Pearls of Knowledge to Consider

1. Telephone consultations of the rst presentation of disease in patients, even
when it seems innocent, are a pitfall that must be avoided.
2. Body and organ descriptions by patients themselves carry substantial risks and
may only be used as a part of medical history but may never substitute the physi­cal examination of the patient, which should be done with the patient in person.
3. Always be extremely careful with patients who express a presentation of a u-
like disease, since a broad spectrum of infectious diseases present themselves as a u-like set of symptoms and signs during the rst days, sometimes even in the rst 2 weeks. The physician must always check for exposure to specic diseases, and especially insect bites or soaring local irritations must be asked for and eval­uated carefully.
4. Early diagnosis and treatment of Lyme disease may prevent more serious pre-
sentations and evolution in the patient with Lyme disease.
45 Early Lyme Disease Misdiagnosed asInuenza
335

Conclusion

Since many infectious diseases present themselves in the early stages immediately after the end of their incubation period initially with u-like symptoms, the recogni­tion of the true underlying disease poses a considerable challenge. Especially dur­ing inuenza season as well as epidemics of other infectious diseases that start likewise, the physician’s task is not easy. As was shown in this case of Lyme dis­ease, but also in other cases like leptospirosis, acute retroviral syndrome in HIV, and other diseases, what appears innocent in the early presentation may spell a poten­tially serious and in some cases even life-threatening evolution, unless recognized early and treated in a timely manner. While u-like symptoms tend to prompt a non-etiological treatment but only symptomatic treatment, serious conditions that start in the same way need a specic treatment, aimed at the underlying cause. Even in case of antibiotics, generic or acquired antimicrobial resistance of the offending agent requires a specic approach.
The difference between the innocent versus serious underlying condition requires two fundamental elements. First is not only the specic knowledge but also the specic attention of the physician for details in the medical history that point to or may even be pathognomonic for serious underlying conditions. It cannot be assumed that the patient may be aware of these details and would mention them spontane­ously or even by answering on an “anything else” basis. Second is the specic knowledge and attention of the physician regarding what to include or exclude at physical examination, as well as in the following diagnostic procedures as labora­tory testing, etc.
Lyme disease belongs to the serious diseases and must be recognized, diagnosed, and treated as soon as possible. It is a diagnosis that cannot be made by telephone consultation; otherwise it will be missed easily. Since early treatment is simple but extremely important, it must be specically considered when u-like symptoms and signs are presented by patients, and the patient should be seen, spoken to, and exam­ined in person by the physician.

References

1. Pritt BS, Mead PS, Hoang Johnson DK.Lancet Infect Dis. 2016 May;16(5):556–64. https://
doi.org/10.1016/S1473- 3099(15)00464- 8.
2. Chomel B.Lyme disease. Rev Sci Tech Off Int Epiz. 2015;34(2):569–76.
3. Lantos PM. Chronic Lyme disease. Infect Dis Clin N Am. 2015;29(2):325–40. https://doi.
org/10.1016/j.idc.2015.02.006.
4. Wormser GP, Dattwyler RJ, Shapiro ED, etal. The clinical assessment, treatment, and preven­tion of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guide­lines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089–134.
5. Klempner MS, Baker PJ, Shapiro ED, etal. Treatment trials for post-Lyme disease symptoms revisited. Am J Med. 2013;126(8):665–9. https://doi.org/10.1016/j.amjmed.2013.02.014.
336
6. Steere AC, Strle F, Wormser GP, etal. Lyme borreliosis. [published correction appears in Nat Rev Dis Primers. 2017 Aug 03;3:17062]. Nat Rev Dis Primers. 2016;2:16090. https://doi.
org/10.1038/nrdp.2016.90.
7. Steere AC.Lyme disease. N Engl J Med. 2001;345(2):115–25.
8. Steere AC.Lyme disease. N Engl J Med. 1989;321:586–96.
9. Coburn J, Garcia B, Hu LT, et al. Lyme disease pathogenesis. Curr Issues Mol Biol. 2021;42:473–518. https://doi.org/10.21775/cimb.042.473.
10. Aucott J, Seifter A.Misdiagnosis of early Lyme diseases as the summer u. Orthop Rev. 2011;3:e14.
11. Branda JA, Steere AC. Laboratory diagnosis of Lyme Borreliosis. Clin Microbiol Rev. 2021;34(2):e00018–9. https://doi.org/10.1128/CMR.00018- 19.
12. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP. Serodiagnosis in early Lyme disease. J Clin Microbiol. 1993;31:3090–5. https://doi.
org/10.1128/JCM.31.12.3090- 3095.1993.
13. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture- conrmed erythema migrans. J Clin Microbiol. 1996;34:1–9. https://doi.org/10.1128/
JCM.34.1.1- 9.1996.
14. Marques A, Schwartz I, Wormser GP, et al. Transcriptome assessment of erythema Migrans skin lesions in patients with early Lyme disease reveals predominant interferon signal­ing. [published correction appears in J Infect Dis. 2021 Feb 3;223(2):352]. J Infect Dis. 2017;217(1):158–67. https://doi.org/10.1093/infdis/jix563.
15. Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, treatment, and preven­tion of Lyme disease, human granulocytic Anaplasmosis, and Babesiosis: a review. JAMA. 2016;315(16):1767–77. https://doi.org/10.1001/jama.2016.2884.
S. Keli